MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

07 Aug 2025 Evaluate
A fair growth of 17.72% in the revenue at Rs. 0.93 millions was reported in the June 2025 quarter as compared to Rs. 0.79 millions during year-ago period.Net profit for the quarter ended June 2025 increased significantly by 90.00% to Rs. 1.71 millions from Rs. 0.90 millions.OP of the company witnessed a marginal growth to 2.57 millions from 1.83 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.93 0.79 17.72 0.93 0.79 17.72 6.11 5.55 10.09
Other Income 5.34 4.57 16.85 5.34 4.57 16.85 20.09 19.92 0.85
PBIDT 2.57 1.83 40.44 2.57 1.83 40.44 10.58 9.10 16.26
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT 2.56 1.83 39.89 2.56 1.83 39.89 10.57 9.10 16.15
Depreciation 0.25 0.24 4.17 0.25 0.24 4.17 0.98 0.98 0.00
PBT 2.31 1.59 45.28 2.31 1.59 45.28 9.59 8.12 18.10
TAX 0.60 0.69 -13.04 0.60 0.69 -13.04 6.42 1.62 296.30
Deferred Tax 0.00 0.39 -100.00 0.00 0.39 -100.00 2.02 1.49 35.57
PAT 1.71 0.90 90.00 1.71 0.90 90.00 3.17 6.50 -51.23
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 276.34 231.65 19.30 276.34 231.65 19.30 173.16 163.96 5.61
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..